DNMT3A and acute myeloid leukemia: Given that the cooccurrence of mutations in TET2, DNMT3A, and FLT3ITD in patients is associated with aggressive AML and with relapse, we assessed the biological consequences of coexistence of these mutations on various hematologic parameters.